Endava plc (DAVA) Facing Securities Class Action Amid Delayed Financials, Potential Improper Accounting, CFO On Leave

Endava shares fell more than 25% on September 22, 2026, after the company disclosed an internal investigation into accounting treatment for certain customer and supplier agreements, placed CFO Mark Thurston on administrative leave, and delayed its quarterly and annual reports. A securities class action alleges the company’s prior financial assurances and statements about momentum in its AI pivot may have been misleading; the allegations have not been established. The suit seeks to represent investors who acquired securities from September 4, 2025, through September 21, 2026, with a lead plaintiff deadline of November 30, 2026.

Analysis

The investable issue is not the class-action filing itself: it is whether the audit review impairs confidence in reported revenue recognition, historical results, or the reliability of future guidance. The lawsuit is an interested plaintiff-firm solicitation, not independent confirmation of the allegations. The September selloff may already price in a substantial uncertainty discount; another short based only on the filing risks a squeeze if the review finds limited adjustments and reporting resumes promptly.

Near term (days to weeks), expect event-driven volatility around disclosures, not a clean read-through from the litigation deadline. Over 1–3 months, the key catalysts are the delayed results, auditor conclusions, any restatement, and evidence that management can re-establish reporting controls. A restatement would matter beyond the accounting adjustment if it undermines confidence in customer demand or the credibility of AI-related growth claims; it would not, by itself, prove AI demand was weak. Over 6–18 months, sustained customer caution or weakened bookings could impair growth expectations and keep valuation multiples depressed. Competitors such as Accenture, Cognizant, and Globant could benefit at the margin if clients shift work away from Endava, but broad peer read-through is not justified absent evidence of customer displacement.

Contrarian point: the lawsuit adds little fundamental information beyond the previously announced review. The asymmetric risk is that undisclosed accounting scope or prolonged reporting delays create further downside, while a prompt, bounded resolution supports a sharp relief move. No valuation or current options data are provided, so avoid asserting a price target or an unconditional options trade.

Key Decisions for Investors

• Keep DAVA underweight/avoid new long exposure until delayed filings and the auditor’s review clarify whether financial statements require adjustment. Treat the Nov. 30 lead-plaintiff deadline as procedural, not a standalone earnings catalyst.
• Do not initiate an outright short solely on this solicitation after the prior gap down. For bearish exposure, first verify borrow availability, current implied volatility, and the timing of the next disclosure; consider defined-risk puts or put spreads only if pricing is acceptable and expiries cover that catalyst window.
• Watch for a relative-value setup: short DAVA against a diversified IT-services basket including Accenture, Cognizant, or Globant only if evidence emerges of customer churn or deteriorating bookings at Endava. The thesis is falsified by timely audited reporting, no material restatement, and stable customer/booking indicators; reassess on any auditor finding, further delay, or guidance revision.